Are you Dr. Chan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
100 Blossoms Street
Cox LL Massachusetts General Hospital
Boston, MA 02114Phone+1 617-724-1159Fax+1 617-726-3603
Summary
- Dr. Annie Chan, MD is a radiation oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Massachusetts Eye and Ear, Massachusetts General Hospital, and Emerson Hospital.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1996 - 2000
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1995 - 1996
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1995
Certifications & Licensure
- MA State Medical License 2000 - 2025
- American Board of Radiology Radiation Oncology
Clinical Trials
- Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma Start of enrollment: 2006 Oct 01
- Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy Start of enrollment: 2011 Jul 12
- Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 3 citationsThe Potential of Adaptive Radiotherapy for Patients With Head and Neck Cancer-Too Much or Not Enough?Beth M Beadle, Annie W Chan
JAMA Oncology. 2023-08-01 - 1 citationsDoes Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?Jeremy D Richmon, Annie W Chan, Peter M Sadow, Lori J Wirth, Tessa Goldsmith
American Journal of Clinical Oncology. 2023-07-01 - 2 citationsDouble trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.Saskia Naegele, Vasileios Efthymiou, Shun Hirayama, Brian Y Zhao, Dipon Das
Head & Neck. 2023-06-01
Press Mentions
- AI Model May Aid in Screening, Staging, and Treatment Planning for Thyroid CancerMarch 3rd, 2022
- Multimodal AI Platform Can Accurately Diagnose and Stage Thyroid Cancer via Ultrasound ImagesFebruary 24th, 2022
- Artificial Intelligence Platform Shows Potential for Thyroid Cancer Screening and Staging from Ultrasound ImagesFebruary 23rd, 2022
- Join now to see all